![](https://endpts.com/wp-content/uploads/2017/09/houston-arvinas-endpoints-endpts-social.jpg)
From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
John Houston spent close to 30 years in the ranks of two big biopharma R&D organizations. There was a decade at GSK followed by 18 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.